Business Context and Reporting Period
Company: AFC Gamma, Inc. (AFCG)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2024
Business Overview: AFCG is an institutional lender specializing in senior secured loans to cannabis industry operators in states where medical and/or adult-use cannabis is legal. The company operates as a Real Estate Investment Trust (REIT).
Material Event: On July 9, 2024, the company completed a spin-off of its commercial real estate (CRE) portfolio into an independent, publicly traded REIT named Sunrise Realty Trust, Inc. (SUNS). Following this transaction, AFCG is solely focused on cannabis-related lending.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2024 |
Six Months Ended June 30, 2024 |
Six Months Ended June 30, 2023 |
|---|---|---|---|
| Net Interest Income | $18.38 million | $33.14 million | $32.93 million |
| Net Income | $16.45 million | $16.39 million | $22.16 million |
| Earnings Per Share (Diluted) | $0.80 | $0.79 | $1.08 |
| Total Assets | $457.99 million (as of June 30, 2024) | ||
| Cash and Cash Equivalents | $170.30 million (as of June 30, 2024) | ||
| Loan Portfolio (Carrying Value, net) | $250.61 million (as of June 30, 2024) | ||
| Debt Obligations | $123.31 million (Senior Notes + Line of Credit) | ||
| Dividends Declared (Common) | $0.63 per share | $1.11 per share | $1.04 per share |
Material Changes vs. Prior Period
- Net Income Decline: Net income for the six months ended June 30, 2024, decreased to $16.39 million from $22.16 million in the prior year period. This was primarily driven by a $5.03 million unrealized loss on loans held at fair value and a decrease in the provision for current expected credit losses (which acted as a gain in the current period but was smaller than the prior year's impact relative to other factors).
- Portfolio Composition: The company sold $90.0 million of loans held at carrying value and $19.3 million of loans held at fair value during the six-month period. New fundings totaled approximately $107.2 million.
- Credit Quality: The Current Expected Credit Loss (CECL) reserve decreased to $25.01 million (9.13% of loans held at carrying value) from $26.31 million at year-end 2023. Three loans totaling approximately $141 million (Private Company A, Subsidiary of Private Company G, and Private Company K) were on nonaccrual status as of June 30, 2024.
- Expense Fluctuations: Professional fees increased by $1.1 million year-over-year for the six-month period, largely due to $1.1 million in spin-off related costs. Stock-based compensation increased by $0.5 million due to equity awards granted in January 2024.
Outlook, Risks, and Management Commentary
- Spin-Off Completion: The separation of the CRE portfolio into SUNS is complete. AFCG will now report the historical results of the SUNS business as discontinued operations starting in Q3 2024. The company retains no ownership in SUNS.
- Liquidity: As of June 30, 2024, the company held $170.3 million in cash and had $25.0 million of availability under its $60.0 million revolving credit facility. Management believes this is sufficient to meet obligations for the next 12 months.
- Dividends: The company declared a special one-time dividend of $0.15 per share in connection with the spin-off, payable July 15, 2024. Regular quarterly dividends remain at $0.48 per share.
- Risk Factors:
- Cannabis Industry Risk: Federal illegality of cannabis creates regulatory and enforcement risks. Borrowers may face license revocation or inability to refinance.
- Concentration Risk: The top three borrowers represent approximately 49.5% of the aggregate outstanding principal balances.
- Interest Rate Risk: Approximately 37% of the portfolio is floating-rate (tied to SOFR). Rising rates increase borrowing costs, though floating assets provide some mitigation.
- Collateral Realization: In the event of default, the company may be prohibited from taking ownership of cannabis assets or licenses, potentially limiting recovery options to selling the loan or foreclosing on real estate collateral.
Investor Verification Checklist
- Spin-Off Accounting: Verify how the Q3 2024 financials will present the SUNS business as discontinued operations and the impact on comparability.
- Nonaccrual Loans: Review the status and recovery prospects of the three loans on nonaccrual status (Private Company A, Subsidiary of Private Company G, Private Company K), which represent a significant portion of the portfolio.
- Debt Covenants: Confirm continued compliance with the 2027 Senior Notes and Revolving Credit Facility covenants, specifically the 25% secured debt limit and liquidity requirements.
- Dividend Sustainability: Assess whether the $1.11 per share dividend payout for the first half of 2024 is sustainable given the net income of $16.39 million and the shift to a purely cannabis-focused portfolio.
- Valuation of Fair Value Loans: Scrutinize the $34.66 million fair value loan (Private Company A) which has an unrealized loss of approximately $15.0 million and is in receivership.